95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.24%
Revenue growth similar to FSM's 13.83%. Walter Schloss would see if both companies share industry tailwinds.
8.19%
Gross profit growth at 75-90% of FSM's 9.34%. Bill Ackman would demand operational improvements to match competitor gains.
7.00%
EBIT growth below 50% of FSM's 43.17%. Michael Burry would suspect deeper competitive or cost structure issues.
7.00%
Operating income growth under 50% of FSM's 43.17%. Michael Burry would be concerned about deeper cost or sales issues.
3.04%
Net income growth under 50% of FSM's 41.82%. Michael Burry would suspect the firm is falling well behind a key competitor.
2.86%
EPS growth under 50% of FSM's 40.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
2.86%
Diluted EPS growth under 50% of FSM's 40.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
11.63%
Positive OCF growth while FSM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-63.01%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
60.86%
10Y revenue/share CAGR under 50% of FSM's 261.60%. Michael Burry would suspect a lasting competitive disadvantage.
54.95%
5Y revenue/share CAGR at 50-75% of FSM's 93.60%. Martin Whitman would worry about a lagging mid-term growth trajectory.
60.21%
3Y revenue/share CAGR 1.25-1.5x FSM's 44.85%. Bruce Berkowitz might see better product or regional expansions than the competitor.
43.28%
10Y OCF/share CAGR at 50-75% of FSM's 68.69%. Martin Whitman might fear a structural deficiency in operational efficiency.
82.95%
Below 50% of FSM's 4553.94%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
82.43%
Positive 3Y OCF/share CAGR while FSM is negative. John Neff might see a big short-term edge in operational efficiency.
4.10%
Below 50% of FSM's 267.31%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
254.38%
Below 50% of FSM's 618.55%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
134.22%
3Y net income/share CAGR above 1.5x FSM's 66.24%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
90.98%
10Y equity/share CAGR at 50-75% of FSM's 138.88%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
25.60%
Below 50% of FSM's 96.97%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
16.45%
3Y equity/share CAGR 1.25-1.5x FSM's 12.84%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Cut dividends over 10 years while FSM stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.20%
Firm’s AR is declining while FSM shows 196.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-31.41%
Inventory is declining while FSM stands at 42.90%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.48%
Negative asset growth while FSM invests at 1.30%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.90%
50-75% of FSM's 3.57%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-98.25%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
16.98%
We expand SG&A while FSM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.